INTRODUCTION {#sec1-1}
============

Infections due to methicillin-resistant *Staphylococcus aureus* (MRSA) are on a rise. MRSA is also present as colonizer in the nasal area, which might be responsible for infection in the patient\'s own wound. Such colonization or superficial infections can be treated effectively with mupirocin. Unfortunately, due to unscrupulous use of this antibiotic, resistance to mupirocin is increasing. In initial clinical trials, a minimum inhibitory concentration (MIC) breakpoint of ≤4 μg/ml, and a corresponding zone diameter breakpoint of ≥18 mm with a 5 mg mupirocin disk was used to define susceptibility.\[[@ref1]\] However, investigators have reported false resistance with this zone diameter breakpoint.\[[@ref2][@ref3]\] Further studies by other workers suggested an MIC breakpoint of ≤2 μg/ml and a corresponding zone diameter breakpoint of ≥14 mm for the 5-μg mupirocin disk.\[[@ref4][@ref5]\] Resistance of MRSA to mupirocin is categorized into two types: Low-level or intermediate resistance (MupI), with MICs of 8-256 μg/ml, and high-level resistance (MupR), with MICs ≥512 μg/ml.\[[@ref6][@ref7]\] A plasmid-mediated *mupA* gene appears to be associated with high-level resistance, while low-level resistance is associated with chromosomal point mutations.\[[@ref8][@ref9][@ref10]\] Another novel gene, *mupB* is also responsible for high-level of mupirocin resistance.\[[@ref11]\] Resistance to mupirocin is phenotypically detected by disc diffusion and also by E-tests. Preliminary screening of mupirocin resistance can be done with 5 μg disc, but those isolates, which gives low zones or no zones to 5 μg mupirocin disc can be discriminated for high- and low-level of resistance to mupirocin by using 200 μg disc if available.\[[@ref6]\] However, with the introduction of E-tests, this confounding factor is removed and a single E-test can tell accurately the zone of inhibition.

As MRSA is one of the leading causes of infections in trauma wounds, a suitable drug is required to control the infections and its colonization. Resistance to mupirocin is on a rise, but few studies documenting the level of resistance in trauma patients are available, especially in developing countries. Hence, this study tries to explore the resistance pattern of MRSA to mupirocin in patients admitted for various traumas and also compares the results between two tests and their cost-effectiveness.

MATERIALS AND METHODS {#sec1-2}
=====================

Collection of clinical isolates {#sec2-1}
-------------------------------

This study was conducted prospectively in an apex trauma center of North India for a period of 2 years from September, 2010 to August, 2012. A total of 240 *S. aureus* isolates from various samples were collected during this time.

Antimicrobial sensitivity {#sec2-2}
-------------------------

All isolates of *S. aureus* were tested for antimicrobial sensitivity pattern of methicillin susceptibility both by the Clinical Laboratory Standard Institute (CLSI) guidelines\[[@ref12][@ref13]\] and using the automated methods by VITEK^®^ 2 compact (bioMιrieux, Durham, US). Those confirmed strains of MRSA were then tested for mupirocin sensitivity. *S. aureus* ATCC 25923 was used as control strain for mupirocin sensitivity and *S. aureus* ATCC 43300 was used for MRSA control in VITEK 2 and disc diffusion tests. Both were included with each test. Sensitivity to mupirocin was tested by (1) disc diffusion (CLSI guidelines) and (2) E-test which was performed in parallel. Disc diffusion was done using the 5 μg mupirocin disc on the standard plate. Mueller--Hinton agar (MHA) was used throughout the study. Suspension of freshly cultured MRSA isolates was made up to a turbidity of 0.5 McFarland and later swabbed on the MHA in three directions to give uniform growth. The plates were incubated aerobically at 37°C. All the plates were read independently by two persons to avoid bias.

### Disc diffusion method {#sec3-1}

Disc diffusion was done using the 5 μg mupirocin disc (HiMedia, Mumbai, India) and results read after overnight incubation at 37°C. Here, a clear circular zone of inhibition or lack of it was noted. Depending on the zone of inhibition, which was measured in millimeters, it was categorized as sensitive, intermediate or resistance. For the interpretation of results using 5 μg mupirocin disc, susceptible was take as ≥14 mm, resistant as ≤13 mm and intermediate for those zone size falling in between the two.\[[@ref4]\] A duplicate test was put up for those isolates whose zone falls near 14 mm to rule out intermediate resistance.

### E-test method {#sec3-2}

E-test strips (bioMιrieux, Lyon, France) were used with an antibiotic concentration gradient in the range of 0.064 μg/ml to 1024 μg/ml. E-test MIC was determined according to the manufacturer\'s guidelines. The test was performed and interpreted according to the manufacturer\'s recommendations. An MIC falling between 8 and 256 μg/ml was taken a low or intermediate resistance, those showing ≥512 μg/ml as highly resistant and those isolates showing MIC \<4 μg/ml were interpreted as sensitive.\[[@ref6][@ref7]\]

The reading of both the 5 μg disc and E-test were noted and compared regarding its efficacy and its cost-effectiveness for use in poor resource countries in general trauma care centers. Furthermore, the various MRSA isolated from different samples of trauma patients were noted and compared with the mupirocin sensitivity.

RESULTS {#sec1-3}
=======

After performing the tests for methicillin resistance, 150 isolates of MRSA were identified out of a total of 240 *S. aureus* isolates. All these isolates were tested for mupirocin sensitivity along with controls in each test batch.

Disc test {#sec2-3}
---------

A clear circular zone of inhibition was obtained in each plate. All the isolates were found to be sensitive (\>14 mm). For better interpretation of results, the zone of inhibition obtained in each was divided into two groups: One with zone size \>14 mm but \<30 mm, which was near the cut-off level of 14 mm and the other group ≥30 mm showing very large sensitive zone \[[Figure 1](#F1){ref-type="fig"}\]. Twelve (8%) isolates had zones falling in the first group near the cut-off level of 14 mm and remaining 138 (92%) in the remaining group. This finding obviates the need of using the 200 μg mupirocin disc, which can help to confirm between low- and high-level resistances. A duplicate test has been put up for those whose zone size was \<30 mm. Reading taken independently by two different persons was noted and mean taken \[[Table 1](#T1){ref-type="table"}\].

![Comparative interpretation of disc diffusion test](JLP-6-91-g001){#F1}

###### 

Comparative evaluation of zone size with MIC levels by E-test

![](JLP-6-91-g002)

E-test {#sec2-4}
------

Here, an elliptical zone was obtained, and reading was taken by two persons independently. Again, all the MRSA strains were found to be sensitive to mupirocin, though the level of sensitivity varied. All the isolates showed MIC \<4 μg/ml. For ease of analysis, the results were divided into two groups: One whose reading falls between ≤0.75 but ≥0.094 μg/ml and the other group where the sensitivity was \<0.094, but \>0.064 μg/ml \[[Figure 2](#F2){ref-type="fig"}\]. A total of 8 (5%) showed readings, which falls between ≤0.75 but ≥0.094 μg/ml and remaining 142 (95%) showed zone size falling between \<0.094 but \>0.064 μg/ml.

![Interpretation of mupirocin E-test](JLP-6-91-g003){#F2}

The detail of comparison between zone diameters with MICs is given in [Table 1](#T1){ref-type="table"}.

Sample wise and patients' distribution of methicillin-resistant *Staphylococcus aureus* in relation to the mupirocin sensitivity {#sec2-5}
--------------------------------------------------------------------------------------------------------------------------------

Of the total 150 strains, 62% (93) of the MRSA isolates were from pus samples, 25% (39) were from blood samples, 5% (8) from tracheal, 2% (3) were contributed equally by tissue and fluid samples and remaining 1% (2) by urine and tips equally.

Comparison of cost between the 5 μg mupirocin disc and E-test {#sec2-6}
-------------------------------------------------------------

We have tried to observe the cost-effectiveness between the two methods. A 5 μg mupirocin vial (HiMedia, Mumbai, India) containing 50 discs cost around 150 INR (3 USD). Since a single disc was used per isolate/test, one test costs around 3 INR (0.1 USD). However, a blister packs of mupirocin E-tests strips (bioMιrieux, Lyon, France) containing 100 strips cost around 15,000 INR (254 USD). As a single strip was used per isolate/test, one test costs around 150 INR (3 USD). Hence, it was clearly evident that using a 5 μg mupirocin disc was far cost-effective compared to that of the E-test.

DISCUSSION {#sec1-4}
==========

Based on our findings, none of the MRSA isolates were mupirocin resistant, and none of the demographic characteristics of the carriers or antibiotic resistance patterns or even the source of the isolates (hospital/community acquired) showed any determinant role in mupirocin sensitivity. The zone diameters of 5 (3.3%) of the strains was 16 mm, which is very close to the resistance zone (\<14 mm) in our study.

The emergence of mupirocin resistance among *S. aureus* isolates has been clearly defined in many parts of the world at different frequencies: Spain 11.3%, USA 13.2%, Trinidad Tobago 26.1%, China 6.6%, India 6%, Turkey 45%, and Korea 5%; however, it does appear to be increasing worldwide.\[[@ref9][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19]\] This shows that one of the effective antibiotics to combat the carriage of MRSA is becoming a cause of concern due to rising resistance. Fortunately, all the isolates from our center were sensitive, which is an encouraging finding. This might be due to reason that use of mupirocin indiscriminately is avoided in our set-up. Studies have also shown a strong co-relation between the low rate of high resistance to mupirocin and reduced usage of mupirocin.\[[@ref20]\]

A review of literature of Indian studies on mupirocin has shown that approximately 6% of mupirocin resistance is prevalent. High-level and low-level mupirocin resistance was detected in 10 (5%) and 2 (1%) *S. aureus* strains, respectively.\[[@ref18]\] Pulsed-field gel electrophoresis analysis of the high-level mupirocin-resistant MRSA isolates revealed the presence of two clones with the majority of strains belonging to one clone, suggesting clonal dissemination.\[[@ref18]\] Another study showed that rates of MuH were found to be 2% in MRSA and 28% in methicillin-resistant coagulase-negative *Staphylococcus* spp.\[[@ref21]\] Another study from Chennai showed that MRSA ST239 isolates showed high-level mupirocin resistance (MIC \> 512 mg/L/mupA+), inducible clindamycin resistance and high-level methicillin resistance (MIC = 256 mg/L). Although, there have been individual reports of mupirocin resistance and inducible clindamycin resistance among MRSA, this must be the first report on the emergence of hospital-acquired MRSA with both mupirocin and inducible clindamycin resistance.\[[@ref22]\] Another tertiary care center study in India showed only 5 (3.3%) mupirocin resistant *Staphylococcus* species: Three high-level and two low-level strains were detected. The MICs for the two low-level and three high-level mupirocin resistant strains were 256 mg/L and ≥512 mg/L each, respectively.\[[@ref23]\] Though many studies have reported on the different resistance patterns of MRSA to mupirocin; however, there is a paucity of studies which actually deals with the cost-effectiveness of the methods, which is required in routine practice for detection of resistance. Hence, our study can supplement these lacunae.

When sensitivity was tested for mupirocin, it was observed that good sensitivity pattern can be detected with both the 5 μg disc and the E-tests; but more accurate values were observed with E-tests compared to the disc test in clinical set-ups. As already mentioned in the introduction, high-level resistance may be detected by agar based 200 μg mupirocin disc or using the broth microdilution assay (single well-containing the 256 μg/ml of mupirocin). Further high resistance can also be detected using the *mupA* targeted PCR or the mupirocin E-test. Disc susceptibility, microdilution and E-test each requires 24 h; but, PCR is faster and requires 6-8 h.\[[@ref24]\] Though PCR is faster and hence can result in faster initiation of treatment, the problem lies in its cost. The total working cost of PCR is more than 5 times the conventional 5 μg mupirocin disc or E-test, which is used routinely. However, studies have shown that neither 5 μg nor 200 μg shows good results regarding the resistance detection even though both are the forms, which are currently available commercially. Palepou *et al*. had shown that 25 μg mupirocin disc showed the best results. The best correlation with agar incorporation MIC was obtained with 25 μg mupirocin discs, which classified correctly 98 (95%) isolates, while worse correlations were noted with 5 μg and 200 μg discs, which are the only types currently available commercially, for which there were 47 and 30 minor errors, respectively.\[[@ref25]\] The MIC found by E-test were the same or lower than those by using agar incorporation,\[[@ref25]\] which is concordant with the findings of our study. The drawback of E-tests is the cost factor, which is a deterrent in routine use in laboratories for testing, especially in low resource country like India. Hence, 5 μg mupirocin disc can be used for routine purposes and supplemented with E-test when results are inconclusive.

CONCLUSIONS {#sec1-5}
===========

Resistance to mupirocin is on a rise throughout the world, though MRSAs isolated from our set-up are still sensitive. Hence, screening of patients on a routine basis can be helpful to keep a check on it. It was observed that using 5 μg mupirocin disc is more cost-effective compared to E-test in countries where resources are limited. This can be done by using 5 μg disc supplemented with E-test whenever needed.
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